Saeid Moghassemi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Saeid Moghassemi has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
- Christiani Andrade Amorim
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
22 shared publications - Arezoo Dadashzadeh
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
16 shared publications Arezoo Dadashzadeh
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
11 shared publicationsRicardo Bentes Azevedo
Laboratory of Nanobiotechnology, Department of Genetics and Morphology, Institute of Biological Sciences, University of Brasília , Brasília DF, Brazil
5 shared publications- Amirhossein Hakamivala
Bioengineering Department, University of Texas Southwestern Medical Center, The University of Texas at Arlington, Arlington, TX, 76019, USA
4 shared publications - Hanne Vlieghe
Pôle de Recherche en Physiopathologie de la Reproduction, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium
4 shared publications
Latest Publications
- Open Access
- 11 October 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (11) , 246
Shedding light on the cancer cell death mechanism in photodynamic therapy
Photodynamic therapy (PDT) employs the interaction of a photosensitizer, light, and molecular oxygen to generate reactive oxygen species, which induce regulated cell death pathways that contribute to tumor eradication and immune modulation. Despite its clinical utility, the determinants of tumor selectivity remain incompletely understood. Current evidence suggests that PDT selectivity does not arise from a single mechanism but rather from the dynamic interplay among photosensitizer properties, tumor architecture, microenvironmental heterogeneity, and host immune responses. Here, we integrate current mechanistic understanding of PDT-induced cell death and discuss how tumor-specific factors, including enhanced permeability and retention, differential transporter expression, and microenvironmental heterogeneity, modulate photosensitizer accumulation. We further examine how photosensitizer subcellular localization, tumor biology, and immune microenvironment shape therapeutic outcomes. This integrated perspective highlights opportunities to guide the selection and optimization of PDT agents and treatment strategies toward improved selectivity and immunogenicity, while reinforcing PDT as a versatile modality within modern cancer therapy. Graphical abstract
- 11 October 2026
- Published by Springer Nature in Apoptosis
- Vol. 31 (11) , 246
Open AccessShedding light on the cancer cell death mechanism in photodynamic therapy
Photodynamic therapy (PDT) employs the interaction of a photosensitizer, light, and molecular oxygen to generate reactive oxygen species, which induce regulated cell death pathways that contribute to tumor eradication and immune modulation. Despite its clinical utility, the determinants of tumor selectivity remain incompletely understood. Current evidence suggests that PDT selectivity does not arise from a single mechanism but rather from the dynamic interplay among photosensitizer properties, tumor architecture, microenvironmental heterogeneity, and host immune responses. Here, we integrate current mechanistic understanding of PDT-induced cell death and discuss how tumor-specific factors, including enhanced permeability and retention, differential transporter expression, and microenvironmental heterogeneity, modulate photosensitizer accumulation. We further examine how photosensitizer subcellular localization, tumor biology, and immune microenvironment shape therapeutic outcomes. This integrated perspective highlights opportunities to guide the selection and optimization of PDT agents and treatment strategies toward improved selectivity and immunogenicity, while reinforcing PDT as a versatile modality within modern cancer therapy. Graphical abstract
- Open Access
- 26 March 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
FSH and GDF-9 modulate extracellular matrix remodeling in human preantral follicles in a 3D hydrogel culture
Human preantral follicle development requires finely tuned signaling between oocytes and granulosa cells, supported by a structured extracellular matrix (E
- 26 March 2026
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 19 (1)
Open AccessFSH and GDF-9 modulate extracellular matrix remodeling in human preantral follicles in a 3D hydrogel culture
Human preantral follicle development requires finely tuned signaling between oocytes and granulosa cells, supported by a structured extracellular matrix (E
- Open Access
- 1 July 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 49, 456-485
The revolutionary role of placental derivatives in biomedical research
The human placenta is a transient yet crucial organ that plays a key role in sustaining the relationship between the maternal and fetal organisms. Despite its historical classification as “biowaste," placental tissues have garnered increasing attention since the early 1900s for their significant medical potential, particularly in wound repair and surgical application. As ethical considerations regarding human placental derivatives have largely been assuaged in many countries, they have gained significant attention due to their versatile applications in various biomedical fields, such as biomedical engineering, regenerative medicine, and pharmacology. Moreover, there is a substantial trend toward various animal product substitutions in laboratory research with human placental derivatives, reflecting a broader commitment to advancing ethical and sustainable research methodologies. This review provides a comprehensive examination of the current applications of human placental derivatives, explores the mechanisms behind their therapeutic effects, and outlines the future potential and directions of this rapidly advancing field.
- 1 July 2025
- Published by KEAI Publishing in Bioactive Materials
- Vol. 49, 456-485
Open AccessThe revolutionary role of placental derivatives in biomedical research
The human placenta is a transient yet crucial organ that plays a key role in sustaining the relationship between the maternal and fetal organisms. Despite its historical classification as “biowaste," placental tissues have garnered increasing attention since the early 1900s for their significant medical potential, particularly in wound repair and surgical application. As ethical considerations regarding human placental derivatives have largely been assuaged in many countries, they have gained significant attention due to their versatile applications in various biomedical fields, such as biomedical engineering, regenerative medicine, and pharmacology. Moreover, there is a substantial trend toward various animal product substitutions in laboratory research with human placental derivatives, reflecting a broader commitment to advancing ethical and sustainable research methodologies. This review provides a comprehensive examination of the current applications of human placental derivatives, explores the mechanisms behind their therapeutic effects, and outlines the future potential and directions of this rapidly advancing field.
- 1 January 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (1-2) , 69-78
Bioprinting of a Liposomal Oxygen-Releasing Scaffold for Ovary Tissue Engineering
This study addresses a critical challenge in bioprinting for regenerative medicine, specifically the issue of hypoxia compromising cell viability in engineered tissues. To overcome this hurdle, a novel approach utilizing a microfluidic bioprinter is employed to create a two-layer structure resembling the human ovary. This structure incorporates a liposomal oxygen-releasing system to enhance cell viability. The bioprinting technique enables the simultaneous extrusion of two distinct bioinks, namely bioink A (comprising alginate 1% and 5mg/ml PEGylated fibrinogen in a 20:1 molar ratio) and bioink B (containing alginate 0.5%). Additionally, liposomal catalase and H2O2 are synthesized and incorporated into bioinks A and B, respectively. The liposomes are prepared using thin film hydration with a monodisperse size (140-160 nm) and high encapsulation efficiency. To assess construct functionality, isolated human ovarian cells are added to bioink A. The bioprinted constructs, with or without liposomal oxygen-releasing systems, are cultured under hypoxic and normoxic conditions for 3 days. Live/Dead assay results demonstrate that liposomal oxygen-releasing systems effectively preserve cell viability in hypoxic conditions, resembling viability under normoxic conditions without liposomes. PrestoBlue assay reveals significantly higher mitochondrial activity in constructs with liposomal oxygen delivery systems under both hypoxic and normoxic conditions. The evaluation of apoptosis status through Annexin V immunostaining shows that liposomal oxygen-releasing scaffolds successfully protect cells from hypoxic stress, exhibiting a proportion of apoptotic cells similar to normoxic conditions. In contrast, constructs lacking liposomes in hypoxic conditions exhibit a higher incidence of cells in early-stage apoptosis. In conclusion, the study demonstrates the promising potential of bioprinted oxygen-releasing liposomal scaffolds to protect ovarian stromal cells in hypoxic environments. These innovative scaffolds not only offer protection but also recapitulate the mechanical differences between the medulla and cortex in the normal ovary structure. This opens new avenues for advanced ovary tissue engineering and transplantation strategies.
- 1 January 2025
- Published by SAGE Publications in Tissue Engineering Part A
- Vol. 31 (1-2) , 69-78
Bioprinting of a Liposomal Oxygen-Releasing Scaffold for Ovary Tissue Engineering
This study addresses a critical challenge in bioprinting for regenerative medicine, specifically the issue of hypoxia compromising cell viability in engineered tissues. To overcome this hurdle, a novel approach utilizing a microfluidic bioprinter is employed to create a two-layer structure resembling the human ovary. This structure incorporates a liposomal oxygen-releasing system to enhance cell viability. The bioprinting technique enables the simultaneous extrusion of two distinct bioinks, namely bioink A (comprising alginate 1% and 5mg/ml PEGylated fibrinogen in a 20:1 molar ratio) and bioink B (containing alginate 0.5%). Additionally, liposomal catalase and H2O2 are synthesized and incorporated into bioinks A and B, respectively. The liposomes are prepared using thin film hydration with a monodisperse size (140-160 nm) and high encapsulation efficiency. To assess construct functionality, isolated human ovarian cells are added to bioink A. The bioprinted constructs, with or without liposomal oxygen-releasing systems, are cultured under hypoxic and normoxic conditions for 3 days. Live/Dead assay results demonstrate that liposomal oxygen-releasing systems effectively preserve cell viability in hypoxic conditions, resembling viability under normoxic conditions without liposomes. PrestoBlue assay reveals significantly higher mitochondrial activity in constructs with liposomal oxygen delivery systems under both hypoxic and normoxic conditions. The evaluation of apoptosis status through Annexin V immunostaining shows that liposomal oxygen-releasing scaffolds successfully protect cells from hypoxic stress, exhibiting a proportion of apoptotic cells similar to normoxic conditions. In contrast, constructs lacking liposomes in hypoxic conditions exhibit a higher incidence of cells in early-stage apoptosis. In conclusion, the study demonstrates the promising potential of bioprinted oxygen-releasing liposomal scaffolds to protect ovarian stromal cells in hypoxic environments. These innovative scaffolds not only offer protection but also recapitulate the mechanical differences between the medulla and cortex in the normal ovary structure. This opens new avenues for advanced ovary tissue engineering and transplantation strategies.
- 24 October 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114338
Metallic-based phthalocyanine nanoemulsions for photodynamic purging of ovarian tissue in leukemia patients
- 24 October 2024
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 245, 114338
Metallic-based phthalocyanine nanoemulsions for photodynamic purging of ovarian tissue in leukemia patients
- 16 August 2024
- Published by Elsevier in Life Sciences
- Vol. 355, 122992
A novel bioprinted microtumour model for studying acute-leukemia-cell- contaminated in ovarian tissue
- 16 August 2024
- Published by Elsevier in Life Sciences
- Vol. 355, 122992
A novel bioprinted microtumour model for studying acute-leukemia-cell- contaminated in ovarian tissue
- Top Cited PapersOpen Access
- 1 June 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 36, 126-156
Extracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells. These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate signaling pathways in recipient cells through fusion or interaction. These nanovesicles possess several desirable properties, making them ideal for regenerative medicine and nanomedicine applications. These properties include exceptional stability, biocompatibility, wide biodistribution, and minimal immunogenicity. However, the practical utilization of sEVs, particularly in clinical settings and at a large scale, is hindered by the expensive procedures required for their isolation, limited circulation lifetime, and suboptimal targeting capacity. Despite these challenges, sEVs have demonstrated a remarkable ability to accommodate various cargoes and have found extensive applications in the biomedical sciences. To overcome the limitations of sEVs and broaden their potential applications, researchers should strive to deepen their understanding of current isolation, loading, and characterization techniques. Additionally, acquiring fundamental knowledge about sEVs origins and employing state-of-the-art methodologies in nanomedicine and regenerative medicine can expand the sEVs research scope. This review provides a comprehensive overview of state-of-the-art exosome-based strategies in diverse nanomedicine domains, encompassing cancer therapy, immunotherapy, and biomarker applications. Furthermore, we emphasize the immense potential of exosomes in regenerative medicine.
- 1 June 2024
- Published by KEAI Publishing in Bioactive Materials
- Vol. 36, 126-156
Top Cited PapersOpen AccessExtracellular vesicles in nanomedicine and regenerative medicine: A review over the last decade
Small extracellular vesicles (sEVs) are known to be secreted by a vast majority of cells. These sEVs, specifically exosomes, induce specific cell-to-cell interactions and can activate signaling pathways in recipient cells through fusion or interaction. These nanovesicles possess several desirable properties, making them ideal for regenerative medicine and nanomedicine applications. These properties include exceptional stability, biocompatibility, wide biodistribution, and minimal immunogenicity. However, the practical utilization of sEVs, particularly in clinical settings and at a large scale, is hindered by the expensive procedures required for their isolation, limited circulation lifetime, and suboptimal targeting capacity. Despite these challenges, sEVs have demonstrated a remarkable ability to accommodate various cargoes and have found extensive applications in the biomedical sciences. To overcome the limitations of sEVs and broaden their potential applications, researchers should strive to deepen their understanding of current isolation, loading, and characterization techniques. Additionally, acquiring fundamental knowledge about sEVs origins and employing state-of-the-art methodologies in nanomedicine and regenerative medicine can expand the sEVs research scope. This review provides a comprehensive overview of state-of-the-art exosome-based strategies in diverse nanomedicine domains, encompassing cancer therapy, immunotherapy, and biomarker applications. Furthermore, we emphasize the immense potential of exosomes in regenerative medicine.
- Open Access
- 21 December 2023
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2024 (1) , hoad052
Influence of ovarian stromal cells on human ovarian follicle growth in a 3D environment
Do ovarian stromal cells (OSCs) influence the viability and growth of human pre-antral follicles in vitro? A feeder layer of oSCs promotes the growth and transition of low developmental stage follicles to the primary/secondary stage while maintaining a high proportion of viable follicles. In the ovary, follicles rely on the support of ovarian cells, which secrete essential factors for their survival and development. This phenomenon has also been demonstrated in vitro through the 3D culture of isolated mouse primary and secondary follicles on a feeder layer of ovarian stromal cells. This co-culture notably enhances follicle survival and growth. Pre-antral follicles were isolated from human frozen-thawed ovarian tissue (OT) biopsies and then encapsulated in 1% alginate scaffolds. These embedded pre-antral follicles were either placed directly on the OSCs feeder layer or at the bottom of a culture dish for a 7-day in vitro culture (control). The study compared follicle viability, growth and hormone production between the different groups. Primordial/intermediate and primary follicles were isolated from frozen-thawed OT of cancer patients (n = 6). Ovarian stromal cells were then isolated from OT of post-menopausal women and cultured as a feeder layer. Follicle diameter was measured on days 0 and 7 using an inverted microscope to assess their development based on the increase in diameter. Viability was evaluated by staining a subset of follicles (n = 87) with calcein AM and ethidium homodimer-I, followed by classification into healthy/minimally damaged and damaged/dead follicles using confocal fluorescence microscopy. Additionally, estradiol levels were measured using ELISA. A total of 382 human preantral follicles (370 primordial/intermediate and 12 primary) with a mean diameter of 40.8 ± 9.9 µm (mean±SD) were isolated, embedded in 1% alginate hydrogel, and placed either on a monolayer of oSCs or directly on the plastic. By Day 7, the preantral follicles showed a significant size increase under both culture conditions (p < 0.0001 for D0 vs D7). The mean diameter of follicles (quiescent and growing) cultured on the feeder layer was 80.6 ± 11.0 μm compared to 67.3 ± 7.2 μm without it (p = 0.07). During the 7-day in vitro culture, the viability of the follicles significantly decreased only in the group without an OSCs monolayer compared to the D0 viability (p < 0.05). Additionally, more follicles transitioned to a higher developmental stage in the presence of OSCs (D0 primordial/intermediate: 184, primary: 7 vs D7 primordial/intermediate: 51, primary/secondary: 93) compared to those cultured without OSCs (D0 primordial/intermediate: 186, primary: 5 vs D7 primordial/intermediate: 84, primary/secondary: 65; p < 0.001). Specifically, 66 and 44 follicles reached the secondary stage (75 < x < 200 μm) in the presence and absence of OSCs, respectively. Moreover, the estradiol level was significantly higher (p = 0.006) in the alginate beads containing primordial and growing follicles cultured on the OSCs (54.1 ± 14.2 pg/ml) compared to those cultured without oSCs (29.9 ± 4.0 pg/ml). N/A This study was conducted using a short-term culture, and none of the primordial/intermediate/primary follicles reached the antral stage. Further in vitro studies are required to investigate follicular developmental capacity, physiology and steroidogenesis in alginate scaffolds with human ovarian stromal cells. Activating and growing human primordial/intermediate follicles to a secondary stage in in vitro short-term culture has posed a longstanding challenge. However, co-culturing with human ovarian stromal cells has shown the potential to overcome this limitation. This study was supported by grants from the Fonds National de la Recherche Scientifique de Belgique (FNRS-PDR Convention grant number T.0004.20 awarded to C.A.A., Ph.D. scholarship awarded to H.V.), Fondation Louvain (awarded to C.A.A.; Ph.D. scholarship awarded to S.M., as part of a legacy from Mr Frans Heyes, and Ph.D. scholarship awarded to A.D. as part of a legacy from Mrs. Ilse Schirmer), Foundation Against Cancer (grant 2018-042 awarded to A.C.), and the European Community Structural Funds and Lithuanian Research Council (Agreement registration No. D-19-0874). The authors have no conflicts of interest to declare.
- 21 December 2023
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2024 (1) , hoad052
Open AccessInfluence of ovarian stromal cells on human ovarian follicle growth in a 3D environment
Do ovarian stromal cells (OSCs) influence the viability and growth of human pre-antral follicles in vitro? A feeder layer of oSCs promotes the growth and transition of low developmental stage follicles to the primary/secondary stage while maintaining a high proportion of viable follicles. In the ovary, follicles rely on the support of ovarian cells, which secrete essential factors for their survival and development. This phenomenon has also been demonstrated in vitro through the 3D culture of isolated mouse primary and secondary follicles on a feeder layer of ovarian stromal cells. This co-culture notably enhances follicle survival and growth. Pre-antral follicles were isolated from human frozen-thawed ovarian tissue (OT) biopsies and then encapsulated in 1% alginate scaffolds. These embedded pre-antral follicles were either placed directly on the OSCs feeder layer or at the bottom of a culture dish for a 7-day in vitro culture (control). The study compared follicle viability, growth and hormone production between the different groups. Primordial/intermediate and primary follicles were isolated from frozen-thawed OT of cancer patients (n = 6). Ovarian stromal cells were then isolated from OT of post-menopausal women and cultured as a feeder layer. Follicle diameter was measured on days 0 and 7 using an inverted microscope to assess their development based on the increase in diameter. Viability was evaluated by staining a subset of follicles (n = 87) with calcein AM and ethidium homodimer-I, followed by classification into healthy/minimally damaged and damaged/dead follicles using confocal fluorescence microscopy. Additionally, estradiol levels were measured using ELISA. A total of 382 human preantral follicles (370 primordial/intermediate and 12 primary) with a mean diameter of 40.8 ± 9.9 µm (mean±SD) were isolated, embedded in 1% alginate hydrogel, and placed either on a monolayer of oSCs or directly on the plastic. By Day 7, the preantral follicles showed a significant size increase under both culture conditions (p < 0.0001 for D0 vs D7). The mean diameter of follicles (quiescent and growing) cultured on the feeder layer was 80.6 ± 11.0 μm compared to 67.3 ± 7.2 μm without it (p = 0.07). During the 7-day in vitro culture, the viability of the follicles significantly decreased only in the group without an OSCs monolayer compared to the D0 viability (p < 0.05). Additionally, more follicles transitioned to a higher developmental stage in the presence of OSCs (D0 primordial/intermediate: 184, primary: 7 vs D7 primordial/intermediate: 51, primary/secondary: 93) compared to those cultured without OSCs (D0 primordial/intermediate: 186, primary: 5 vs D7 primordial/intermediate: 84, primary/secondary: 65; p < 0.001). Specifically, 66 and 44 follicles reached the secondary stage (75 < x < 200 μm) in the presence and absence of OSCs, respectively. Moreover, the estradiol level was significantly higher (p = 0.006) in the alginate beads containing primordial and growing follicles cultured on the OSCs (54.1 ± 14.2 pg/ml) compared to those cultured without oSCs (29.9 ± 4.0 pg/ml). N/A This study was conducted using a short-term culture, and none of the primordial/intermediate/primary follicles reached the antral stage. Further in vitro studies are required to investigate follicular developmental capacity, physiology and steroidogenesis in alginate scaffolds with human ovarian stromal cells. Activating and growing human primordial/intermediate follicles to a secondary stage in in vitro short-term culture has posed a longstanding challenge. However, co-culturing with human ovarian stromal cells has shown the potential to overcome this limitation. This study was supported by grants from the Fonds National de la Recherche Scientifique de Belgique (FNRS-PDR Convention grant number T.0004.20 awarded to C.A.A., Ph.D. scholarship awarded to H.V.), Fondation Louvain (awarded to C.A.A.; Ph.D. scholarship awarded to S.M., as part of a legacy from Mr Frans Heyes, and Ph.D. scholarship awarded to A.D. as part of a legacy from Mrs. Ilse Schirmer), Foundation Against Cancer (grant 2018-042 awarded to A.C.), and the European Community Structural Funds and Lithuanian Research Council (Agreement registration No. D-19-0874). The authors have no conflicts of interest to declare.
- 18 September 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 231, 113562
Liposomal oxygen-generating hydrogel for enhancing cell survival under hypoxia condition
- 18 September 2023
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 231, 113562
Liposomal oxygen-generating hydrogel for enhancing cell survival under hypoxia condition